GlassScriptPhysician profile
Rama Valluru
NPI 1619297256
$1,680.57
in general payments reported to CMS, 2019-2025
9 companies · $214 in 2025
The $214 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $120 · 2021: $246 · 2022: $125 · 2023: $376 · 2024: $275 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $496.47 | 2019-2023 | Shingrix |
| Abbott Laboratories | $325.00 | 2023-2024 | Xience Sierra, Freestyle Libre 3 |
| Boston Scientific Corporation | $216.58 | 2020-2025 | Watchman Flx |
| Merck Sharp & Dohme LLC | $125.00 | 2024 | Vaxneuvance |
| Insmed, INC. | $121.34 | 2021 | |
| Shire North American Group INC | $118.73 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $117.86 | 2025 | |
| Gilead Sciences, INC. | $83.63 | 2019 | |
| Intuitive Surgical, INC. | $75.96 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rama Valluru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.